Financial results - TOTAL PHARM SRL

Financial Summary - Total Pharm Srl
Unique identification code: 16629644
Registration number: J2004001113321
Nace: 6820
Sales - Ron
14.474
Net Profit - Ron
5.004
Employees
1
Open Account
Company Total Pharm Srl with Fiscal Code 16629644 recorded a turnover of 2024 of 14.474, with a net profit of 5.004 and having an average number of employees of 1. The company operates in the field of Închirierea şi subînchirierea bunurilor imobiliare proprii sau închiriate having the NACE code 6820.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Total Pharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 7.337 13.976 17.759 17.459 17.326 16.965 15.902 13.383 14.556 14.474
Total Income - EUR 7.204 14.007 17.759 17.459 17.326 16.965 15.902 13.383 14.556 14.474
Total Expenses - EUR 8.399 4.543 4.330 4.170 4.274 5.232 4.547 5.474 11.752 8.490
Gross Profit/Loss - EUR -1.196 9.464 13.429 13.289 13.051 11.732 11.355 7.909 2.804 5.984
Net Profit/Loss - EUR -1.773 9.044 12.896 12.765 12.533 11.249 10.878 7.611 2.661 5.004
Employees 0 0 0 0 0 1 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the company showed steady performance compared to the previous year. The Net Profit increased by 2.357 euro, from 2.661 euro in 2023, to 5.004 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Total Pharm Srl

Rating financiar

Financial Rating -
TOTAL PHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Total Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Total Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Total Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Total Pharm Srl - CUI 16629644

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 43.411 41.305 39.001 36.709 34.453 32.283 30.085 28.691 27.121 25.495
Current Assets 3.335 2.936 1.760 2.046 5.626 13.024 12.170 2.979 2.006 2.714
Inventories 0 0 0 0 0 0 0 0 0 0
Receivables 559 358 381 393 364 1.609 1.030 806 431 343
Cash 2.776 2.578 1.379 1.653 5.262 11.415 11.141 2.173 1.575 2.371
Shareholders Funds 27.070 35.838 35.559 35.012 34.349 44.947 32.980 30.351 25.400 27.616
Social Capital 16.873 16.701 16.418 16.117 15.805 15.505 15.161 15.208 15.162 15.077
Debts 19.675 8.403 5.202 3.743 5.730 360 9.275 1.318 3.727 594
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "6820 - 6820"
CAEN Financial Year 6820
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 2.714 euro in 2024 which includes Inventories of 0 euro, Receivables of 343 euro and cash availability of 2.371 euro.
The company's Equity was valued at 27.616 euro, while total Liabilities amounted to 594 euro. Equity increased by 2.357 euro, from 25.400 euro in 2023, to 27.616 in 2024.

Risk Reports Prices

Reviews - Total Pharm Srl

Comments - Total Pharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.